Literature DB >> 14521037

A pharmacist-managed clinic for treatment of latent tuberculosis infection in health care workers.

Sandra M Tavitian1, Viola H Spalek, Raymond P Bailey.   

Abstract

A pharmacist-managed clinic for treating latent tuberculosis infection (LTBI) in health care workers (HCWs) is described. The hospital-based clinic was begun in 1993 after a review showed that only 0.8% of HCWs at the institution who were prescribed isoniazid for LTBI completed it. The goals of the clinic are to improve HCWs' adherence to LTBI treatment, enhance outcomes, and minimize adverse drug reactions. The clinic is staffed by a pharmacist, a medical resident, and a nurse. If an employee is diagnosed with LTBI, he or she is referred to the clinic, where the pharmacist conducts an initial assessment and provides information on medication available for treatment. The worker is then scheduled for monthly follow-up visits with the pharmacist for the first three months of LTBI therapy, during which the pharmacist evaluates treatment adherence and potential adverse effects. Thereafter, the pharmacist interviews the patient monthly by telephone until therapy is complete. HCWs are allowed only a one-month supply of medication with each refill. From June 1993 through June 1997, of 131 employees who started treatment, 122 (93%) completed it. From June 1997 through December 2001, annual therapy completion rates ranged from 90% to 100%. No cases of active tuberculosis have been reported in treated patients, and only nine adverse drug reactions were reported for the 1997-2001 period. A pharmacist-managed clinic substantially improved rates of treatment completion among HCWs with LTBI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521037     DOI: 10.1093/ajhp/60.18.1856

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  6 in total

1.  The use of anti-tuberculosis therapy for latent TB infection.

Authors:  Justin T Denholm; Emma S McBryde
Journal:  Infect Drug Resist       Date:  2010-07-21       Impact factor: 4.003

2.  Adherence: a review of education, research, practice, and policy in the United States.

Authors:  Nathaniel M Rickles; Todd A Brown; Melissa S Mcgivney; Margie E Snyder; Kelsey A White
Journal:  Pharm Pract (Granada)       Date:  2010-03-15

3.  Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay.

Authors:  Hyun Lee; Gun Woo Koo; Ji-Hee Min; Tai Sun Park; Dong Won Park; Ji-Yong Moon; Sang-Heon Kim; Tae Hyung Kim; Ho Joo Yoon; Jang Won Sohn
Journal:  Sci Rep       Date:  2019-01-11       Impact factor: 4.379

4.  Initiation and completion rates for latent tuberculosis infection treatment: a systematic review.

Authors:  Andreas Sandgren; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anke Stuurman; Anouk Oordt-Speets; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-05-17       Impact factor: 3.090

Review 5.  Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives.

Authors:  Kiyofumi Yamada; Toshitaka Nabeshima
Journal:  J Pharm Health Care Sci       Date:  2015-01-28

6.  Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department.

Authors:  Bernadette Jakeman; Stefanie J Logothetis; Melissa H Roberts; Amy Bachyrycz; Diana Fortune; Matthew E Borrego; Julianna Ferreira; Marcos Burgos
Journal:  Prev Chronic Dis       Date:  2020-02-13       Impact factor: 2.830

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.